drugset / Trial / NCT05871606
Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and feasibility of using inhaled nitric oxide (iNO) in patients undergoing intra-arterial mechanical thrombectomy (blood clot extraction or IAMT) for treatment of acute ischemic (non-bleeding) stroke (AIS).
Timeline
- Start
- 2026-04-16
- Primary completion
- 2028-08-01
- Completion
- 2028-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | iNO | Unknown | 20 ppm | Inhaled |
| Subject | iNO | Unknown | 40 ppm | Inhaled |
| Subject | iNO | Unknown | 50 ppm | Inhaled |
| Subject | iNO | Unknown | 60 ppm | Inhaled |
| Subject | iNO | Unknown | 70 ppm | Inhaled |
| Subject | iNO | Unknown | 80 ppm | Inhaled |